FDA Warns of Overdoses of Anti-Diarrhea Drug

Share this content:
FDA Warns of Overdoses of Anti-Diarrhea Drug
FDA Warns of Overdoses of Anti-Diarrhea Drug

WEDNESDAY, June 8, 2016 (HealthDay News) -- Overdoses from common anti-diarrhea drugs are being investigated by the U.S. Food and Drug Administration, which warned the drugs can cause potentially fatal heart problems when taken in higher-than-recommended amounts.

Loperamide is the main ingredient in prescription Imodium and similar non-prescription drugs meant to control diarrhea. Most of the reported serious heart problems have occurred in individuals who were intentionally misusing/abusing high doses of loperamide in attempts to self-treat opioid withdrawal symptoms or to achieve a feeling of euphoria, the FDA reported.

The FDA notes that the risk of serious heart problems, including abnormal heart rhythms, may be further increased when high doses of loperamide are taken with several kinds of medicines that interact with loperamide. These medications include cimetidine, erythromycin, ketoconazole, and ranitidine.

"Health care professionals should be aware that use of higher than recommended doses of loperamide can result in serious cardiac adverse events," the FDA said in a June 7 safety announcement. "Consider loperamide as a possible cause of unexplained cardiac events, including QT interval prolongation, Torsades de Pointes or other ventricular arrhythmias, syncope, and cardiac arrest."

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Naloxone Price Hikes Could Affect Rates of Opioid-Related Deaths

Naloxone Price Hikes Could Affect Rates of Opioid-Related ...

Investigators identify strategies for ensuring the drug's availability

Suicide Risk Up for Patients With Acute Coronary Syndrome

Suicide Risk Up for Patients With Acute Coronary ...

Findings underscore importance of depression screening, researcher says

SABCS: Molecular Changes Occur When Breast CA Spreads to Brain

SABCS: Molecular Changes Occur When Breast CA Spreads ...

Finding might lead to better treatment, researchers say

is free, fast, and customized just for you!

Already a member?

Sign In Now »